Eurointervention

Papers
(The TQCC of Eurointervention is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity203
In search of the origin of the acronym TAVI167
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis151
Double-tap to treat paravalvular leak in high-risk annuli144
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation120
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry100
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement83
Transcatheter left ventriculoplasty71
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s71
Recanalisation of coronary chronic total occlusions61
Defer-based non-stenting: a promising approach for STEMI60
The “road travelled”: reflections on the transformation of information exchange in a digital age55
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure55
   Atrial fibrillation and acute coronary syndrome 51
One-month DAPT after acute coronary syndrome: too short or not too short?49
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study49
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection45
Hybrid coronary revascularisation: the best or the worst of both worlds?41
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document40
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudy39
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes36
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial36
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD36
Redo transcatheter mitral valve replacement in mitral annular calcification36
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement34
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study34
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons32
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study31
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial31
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation30
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry29
Five-year follow-up of transcatheter tricuspid valve replacement with the EVOQUE valve29
Retrievable scaffold therapy before paclitaxel drug-coated balloon angioplasty in infrapopliteal arteries: one-year outcomes of the DEEPER OUS Study29
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty28
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation28
Cerebral embolic protection during transcatheter heart interventions28
Antithrombotic therapy for transcatheter structural heart intervention27
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry27
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation26
Shifting focus in bifurcations.25
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders24
Carbon footprint of diagnostic coronary angiography23
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial23
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients22
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure22
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons21
Timing of transcatheter aortic valve implantation in patients with aortic stenosis21
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome21
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?21
FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial19
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome19
TRICURE: first-in-human study of the Topaz transcatheter tricuspid heart valve system19
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons19
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 19
Transcatheter treatment of bicuspid aortic valve stenosis19
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial18
The patent foramen ovale does not spontaneously close in patients aged 6017
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation17
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair16
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias16
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation15
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation15
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin15
Stent underexpansion in the CRUNCH registry: worth cracking?15
Transcatheter aortic valve alignment: substantial progress, remaining gaps15
Targeting inflammation in atherosclerosis: overview, strategy and directions15
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI14
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?14
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?14
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry13
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis12
Letter: Caffeine and fractional flow reserve overestimation: a word of caution12
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease12
0.16172289848328